ReviewJournal of cardiothoracic surgery2025
Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature.
Review in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- AI-Derived Pericardial Effusion Volume and Long-Term Mortality After Transcatheter Aortic Valve Implantation.Journal of clinical medicine · 2026Article
- Cardiac Tamponade in Late Pregnancy Caused byJournal of clinical medicine · 2026Article
- Readmission and survival of hospitalized pulmonary tuberculosis patients: a nationwide record-based cohort analysis in Thailand (2017-2022).Infectious diseases of poverty · 2026Article
- Asymptomatic bacteriuria as a warning sign of purulent pericardial effusion in a patient with systemic lupus erythematosus: a case report.Journal of medical case reports · 2026Article
- Aetiologies of pericardial effusion among medical patients at Nelson Mandela Academic Hospital, Mthatha, South Africa: A cross-sectional study.Journal of the colleges of medicine of South Africa · 2026Article
- Role of Multimodal Cardiac Imaging in Pericardial Effusions and Tamponade.Methodist DeBakey cardiovascular journal · 2026Review
- Etiological distribution and mortality factors in pericardial effusion: Insights from a large cohort study.Global cardiology science & practice · 2025Article
- Hemopericardium Following Norovirus Gastroenteritis in a Child: An Uncommon Presentation.Cureus · 2025Article
- Cardiac Endocrine Function and Hormonal Interplay in Pediatrics: From Development to Clinical Implications.Biomedicines · 2025Review
- A Shocking Complication: Right Ventricular Pacemaker Lead Perforation Presenting With Intractable Hiccups.Cureus · 2025Article
- Pericardial Effusion: Overview of Aetiology, Pathophysiology, Diagnosis, and Management.Cureus · 2025Review
- Understanding Hemodialysis-Associated Pericarditis: Causes, Symptoms, and Management Strategies.Journal of clinical medicine · 2025Review
- Article
- Pharmacovigilance study on old drugs repurposed for rare diseases across different indications: the case of fenfluramine.Frontiers in pharmacology · 2025Article
- Case Report: Application of controlled pericardial drainage in type A aortic dissection complicated by cardiac tamponade.Frontiers in cardiovascular medicine · 2025Article
- Transient Supine-Induced Advanced Heart Block in an Octogenarian.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pericardial effusion is a relatively common complication associated with inflammatory and non-inflammatory diseases. The primary etiology of this condition could be considered when choosing therapeutic options and factors such as effusion size and its hemodynamic consequence. In most cases, small to moderate pericardial effusions can be managed with observation and anti-inflammatory medications unless the effusion develops rapidly. However, in a small proportion of patients, large effusions lead to impaired cardiac filling with hemodynamic compromise and cardiovascular collapse due to cardiac tamponade. The rate at which fluid accumulates is the primary determinant of hemodynamic impact and thus guides the choice of treatment, irrespective of the effusion's size. Severe cases are typically treated with pericardiocentesis with echocardiographic guidance. More aggressive treatments may be necessary for cases due to purulent or malignant etiologies. These cases may require a pericardial window to allow for long-term drainage of the pericardial fluid. This comprehensive review focuses on the epidemiology of pericardial effusion and discusses pathophysiology, diagnostic approaches, and therapeutic options for different causes of secondary pericardial effusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.